Your browser doesn't support javascript.
loading
Pharyngeal spasticity due to dantrolene.
Locatelli, F; Pozzi, M; Avantaggiato, P; Lanfranchi, M; Tufarulo, L; Amorelli, V; Rizzi, G; Radice, S; Galbiati, S; Clementi, E; Strazzer, S.
Affiliation
  • Locatelli F; Scientific Institute, IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
J Clin Pharm Ther ; 39(4): 449-51, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24725261
ABSTRACT
WHAT IS KNOWN AND

OBJECTIVE:

Dantrolene can be combined with baclofen to better treat spasticity, but may cause muscular weakness and dysphagia. We instead describe a pharyngeal spasm due to dantrolene. CASE

SUMMARY:

A 12-year-old male received dantrolene 3 mg/kg/day in adjunct to baclofen 2 mg/kg/day, to improve spasticity. After 5 days of full-dose dantrolene, his dysphagia worsened and he developed pharyngeal spasm. Dantrolene was suspected for an adverse reaction and removed. The patient subsequently improved. WHAT IS NEW AND

CONCLUSION:

Causality analysis determined a probable relationship between dantrolene and pharyngeal spasm. This may be due to direct muscle contraction by dantrolene, an effect seen previously in vitro.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharyngeal Diseases / Dantrolene / Muscle Relaxants, Central / Muscle Spasticity Limits: Child / Humans / Male Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharyngeal Diseases / Dantrolene / Muscle Relaxants, Central / Muscle Spasticity Limits: Child / Humans / Male Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country: